CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in CDXS — Codexis, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in CDXS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$394,803
-$53,280 QoQ
Shares Held
242,211
-11.9% QoQ
Ownership
0.266%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $5,925,631,926 across 288 Biotechnology names. CDXS ranks #220 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in CDXS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $394,803 | 242,211 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $448,083 | 274,898 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $611,786 | 250,732 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $611,771 | 250,726 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $673,172 | 250,250 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $1,143,464 | 239,720 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $658,097 | 213,668 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $662,057 | 213,567 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $713,893 | 204,554 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $645,788 | 211,734 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $288,049 | 152,407 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,644,728 | 587,403 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,616,769 | 632,070 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,928,255 | 628,381 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,712,768 | 612,668 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,960,536 | 569,841 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $11,327,741 | 549,357 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $14,133,789 | 451,992 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $9,573,397 | 411,582 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $9,023,665 | 398,220 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $8,852,295 | 386,732 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $7,958,563 | 364,570 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,028,616 | 343,153 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,858,580 | 338,472 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $3,526,392 | 315,985 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||